Replimune Group, Inc. (REPL)
7.58
-0.32
(-4.05%)
USD |
NASDAQ |
Mar 12, 16:00
7.51
-0.07
(-0.92%)
After-Hours: 20:00
Replimune Group Market Cap : 625.90M for March 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.856B |
| Sarepta Therapeutics, Inc. | 1.789B |
| REGENXBIO, Inc. | 459.66M |
| Bristol Myers Squibb Co. | 120.05B |
| Mirum Pharmaceuticals, Inc. | 5.417B |
Market Cap Related Metrics
| PEG Ratio | -0.1516 |
| Price to Book Value | 2.973 |
| Price | 7.58 |
| Earnings Yield | -47.26% |
| PEGY Ratio | -0.1516 |